论文部分内容阅读
目的了解艾滋病抗病毒治疗(ART)病例的生存时间,探讨其相关影响因素。方法收集黔南州2007~2015年的艾滋病ART死亡病例,建立Excel数据库并用SPSS 18.0软件进行分析。结果截至2015年4月全州共有167例治疗病例死亡,男性发病131例,女性发病36例,男女比为3.6∶1。死亡年龄为30~4 0岁占35.33%,>40岁占53.29%;从治疗到死亡的生存时间<3个月者64例,占38.32%;治疗前病人CD4+T淋巴细胞计数水平与病例治疗后的生存时间有关(P<0.05),抗病毒治疗死亡病例不同性别的死亡原因构成差异有统计学意义(P<0.05)。死亡原因以艾滋病相关疾病为主,占52.10%。结论晚发现、晚治疗是导致艾滋病患者死亡的主要原因,应制定有效措施促进检测和治疗,并进一步提高随访质量和规范死亡报告程序。
Objective To understand the survival time of AIDS patients with ART and to explore the related factors. Methods AIDS deaths from 2007 to 2015 in Qiannan Prefecture were collected. An Excel database was established and analyzed by SPSS 18.0 software. Results As of April 2015, a total of 167 treatment deaths were reported across the state. There were 131 males and 36 females with a ratio of 3.6 to 1. The age of death was 35.33% from 30 to 40 years old, accounting for 53.29%> 40 years old. The survival time from treatment to death was 64 cases (<38.32%) <3 months. The CD4 + T lymphocyte count (P <0.05). There was a statistically significant difference in the causes of death among different sex death cases after antiviral therapy (P <0.05). The main cause of death was AIDS-related diseases, accounting for 52.10%. Conclusion Late found that late treatment is the leading cause of AIDS deaths, effective measures should be developed to promote detection and treatment, and to further improve the quality of follow-up and standardize the reporting process of death.